In the spotlight is an initiative by PSS that features hospital pharmacists who excel in their area of practice and are role models for fellow pharmacists.
HSA Drug Safety Information Updates: Retail level recall of eight brands of ranitidine products found to contain N-nitrosodimethylamine (NDMA).
HSA adverse drug reaction including updates on E-labelling and guide on iatrogenic Cushing’s Syndrome and steroid-related adverse events
Singapore National Asthma Program -2 (SNAP2) has put together some key changes to the GINA guidelines in asthma management. The changes include the role of SABA-only treatment and ICS in asthma. Find out more in this bulletin.
